Back to search

Article

Ivermectin Reduces Withdrawal-Induced Alcohol Intake via CeA GABAergic Enhancement

2025-10-15

Abstract excerpt

Although FDA-approved medications for alcohol use disorder (AUD) are available, their efficacy varies across patients, highlighting the need for novel therapeutics that address inter-individual differences in disease etiology and treatment response. Genetic models, particularly heterogeneous stock (HS) rats, recapitulate human-like genetic diversity and behavioral heterogeneity, enabling the dissection of individu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2e502027-0fe0-5dbb-8e65-0106efaa9ba4
DOI
10.1101/2025.10.14.682432
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ivermectin Reduces Withdrawal-Induced Alcohol Intake via CeA GABAergic EnhancementDOI 10.1101/2025.10.14.682432
Distinct Chrna5 mutations link excessive alcohol use to types I/II vulnerability profiles and IPN GABAergic neurons.Semantic proximity
Understanding the addiction cycle: a complex biology with distinct contributions of genotype vs. sex at each stage.Semantic proximity
Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.Semantic proximity
Current Pharmacotherapies for Alcohol Use Disorder in Italy: From Neurobiological Targets to Clinical PracticeSemantic proximity
Neuroinflammatory Responses and Blood–Brain Barrier Injury in Chronic Alcohol Exposure: Role of Purinergic P2X7 Receptor SignalingSemantic proximity
A translational rodent model of individual differences in sensitivity to the aversive properties of ethanolSemantic proximity
Opioid neuroscience for addiction medicine: From animal models to FDA approval for alcohol addiction.Semantic proximity
The FDA-approved drug apremilast suppresses alcohol intake: clinical and pre-clinical validationSemantic proximity
Molecular fingerprints in the hippocampus of alcohol seeking during withdrawalSemantic proximity
A multi-symptomatic model of heroin use disorder in rats reveals distinct behavioral profiles and neuronal correlates of heroin vulnerability versus resiliencySemantic proximity
OPRM1 rs1799971 Polymorphism Predicts Differential Response to Extended-Release Naltrexone in Alcohol Use Disorder: The Interplay of Genetics and Motivation.Semantic proximity
An operant ethanol self-administration paradigm that discriminates between appetitive and consummatory behaviors reveals distinct behavioral phenotypes in commonly used rat strains.Semantic proximity
Select a neighboring publication to make it the new centre.